id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1231018,3197d4e4-e9ac-4c36-bc1c-6a2e8314f48c,Q1,AMERICA'S BLOOD CENTERS,3834,AMERICA'S BLOOD CENTERS,2012,first_quarter,TAX,"Section 4191 of the Internal Revenue Code, enacted by section 1405 of the Health Care and Education Reconciliation Act of 2010, Public Law 111-152 (124 Stat. 1029 (2010)), in conjunction with the Patient Protection and Affordable Care Act, Public Law 111-148 (124 Stat. 119 (2010)) (jointly, the ACA) imposing an excise tax on the sale of certain medical devices by the manufacturer, producer, or importer of the device in an amount equal to 2.3 percent of the sale price.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Institutes of Health (NIH),SENATE",,19000,0,0,2012-04-18T09:39:35.037000-04:00